Distinct Genetic Variants significantly influence an individual’s immune response to the SARS-CoV-2 virus and may influence the COVID-19 disease severity. A research group led by MedUni Vienna was able to demonstrate that Distinct Genetic Variants of the CD16a antibody receptor are associated with the risk of severe COVID-19. This affects around 15% of the population. The results were now published in the journal “Genetics in Medicine”. Natural killer cells (NK cells) play a significant role in combating the viral replication in the initial stages of viral infections. NK cells have specialized receptors on their surface that bind to antibodies that

Distinct genetic variants influence COVID-19 severity as seen on The Hippocratic Post.